Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-49
Shibata, J H W; Hasegawa, J; Siemens, H J; Wolber, E; Dibbelt, L; Li, D; Katschinski, D M; Fandrey, J; Jelkmann, W; Gassmann, M; Wenger, R H; Wagner, K F (2003). Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood, 101(11):4416-4422.
View at publisher
We have generated a transgenic mouse line that reaches a hematocrit concentration of 0.85 due to constitutive overexpression of human erythropoietin in an oxygen-independent manner. Unexpectedly, this excessive erythrocytosis did not lead to thrombembolic complications in all investigated organs at any age. Thus, we investigated the mechanisms preventing thrombembolism in this mouse model. Blood analysis revealed an age-dependent elevation of reticulocyte numbers and a marked thrombocytopenia that matched the reduced megakaryocyte numbers in the bone marrow. However, platelet counts were not different from wild-type controls, when calculations were based on the distribution (eg, plasma) volume, thereby explaining why thrombopoietin levels did not increase in transgenic mice. Nevertheless, bleeding time was significantly increased in transgenic animals. A longitudinal investigation using computerized thromboelastography revealed that thrombus formation was reduced with increasing age from 1 to 8 months in transgenic animals. We observed that increasing erythrocyte concentrations inhibited profoundly and reversibly thrombus formation and prolonged the time of clot development, most likely due to mechanical interference of red blood cells with clot-forming platelets. Transgenic animals showed increased nitric oxide levels in the blood that could inhibit vasoconstriction and platelet activation. Finally, we observed that plasmatic coagulation activity in transgenic animals was significantly decreased. Taken together, our findings suggest that prevention of thrombembolic disease in these erythrocytotic transgenic mice was due to functional consequences inherent to increased erythrocyte concentrations and a reduction of plasmatic coagulation activity, the cause of which remains to be elucidated.
169 downloads since deposited on 11 Feb 2008
42 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||05 Vetsuisse Faculty > Institute of Veterinary Physiology|
|Dewey Decimal Classification:||570 Life sciences; biology|
|Deposited On:||11 Feb 2008 12:12|
|Last Modified:||11 Dec 2013 18:05|
|Publisher:||American Society of Hematology|
|Additional Information:||This research was originally published in Blood, 2003; 101(11):4416-4422. Copyright by the American Society of Hematology|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page